Skip Navigation

Text From Here.

English Publication 2010

  1. Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M,Yamaue H, Yoshikawa T, Kojima K; JCOG Gastric Cancer Surgical Study Group: Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer. 13(4):238-44, 2010
  2. Kawai M,Yamaue H: Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today. 40(11):1011-7, 2010
  3. Iwahashi M, Katsuda M, Nakamori M, Nakamura M, Naka T, Ojima T, Iida T,Yamaue H: Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in? patients with metastatic esophageal squamous cell carcinoma.  Cancer Sci 101(12):2510-7, 2010
  4. Shigekawa Y, Kobayashi Y, Higashiguchi T, Nasu T, Yamamoto M, Ochiai M, Tsuji T,Yamaue H: Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case. Surgery Today 40(10): 972-4, 2010
  5. Uchiyama K, Ueno M, Ozawa S, Kiriyama S, Shigekawa Y, Yamaue H: Combined Use of Contrast-Enhanced Intraoperative Ultrasonography and a Fluorescence Navigation System for Identifying Hepatic Metastases. World J Surg. 34(12):2953-9, 2010
  6. Nishioka R, Itoh S, Gui T, Gai Z, Oikawa K, Kawai M, Tani M, Yamaue H, Muragaki Y: SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. Exp Mol Pathol 89(2): 149-57, 2010
  7. Yoshikawa T, Omura K, Kobayashi O, Nashimoto A, Takabayashi A, Yamada T, Yamaue H, Fujii M, Yamaguchi T, Nakajima T: A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). EJSO 36:546-551, 2010
  8. Shimamoto T, Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Uchiyama K, Yokoyama S, Tsutsumi M, Yamaue H: MUC1 Is A Useful Molecular Marker for Malignant Intraductal Papillary Mucinous Neoplasms in Pancreatic Juice Obtained from Endoscopic Retrograde Pancreatography. Pancreas 39(6): 879-83, 2010
  9. Hayami S, Yoshimatsu M, Veerakumarasivam A, Unoki M, Iwai Y, Tsunoda T, Field HI, Kelly JD, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R: Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer 9(1):59, 2010
  10. Yokoyama S, Takifuji K, Hotta T, Matsuda K, Tominaga T, Oku Y, Nasu T, Tamura K, Ieda J, Yamaue H: Moderately differentiated colorectal adenocarcinoma as a lymph node metastatic phenotype: comparison with well differentiated counterparts. BMC Surg. 10:8, 2010
  11. Kitahata Y, Yokoyama S, Takifuji K, Hotta T, Matsuda K, Tominaga T, Oku Y, Watanabe T, Ieda J, Yamaue H: Hemangiopericytoma in the sacrococcygeal space: a case report. Journal of Medical Case Reports 4:8, 2010
  12. Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Yamaue H: A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy.? Am J Surg. 199(6):759-64, 2010
  13. Ina S, Hirono S, Noda T, Yamaue H: Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of Interferon stimulated gene 15kDa is associated with intrinsic chemoresistance. Pancreas 39(4):473-85, 2010
  14. Miyazawa M, Ohsawa R, Tsunoda T, Hirono S, Kawai M, Tani M, Nakamura Y, Yamaue H: Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. Cancer Sci. 101(2): 433-9, 2010
  15. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, Iida T, Tsuji T, Hayata K, Takifuji K, Yamaue H : Clinicopathological Characteristics of Remnant Gastric Cancer After a Distal Gastrectomy. J Gastrointest Surg. 14(2): 277-81, 2010
  16. Hirono S, Yamaue H, Hoshikawa Y, Ina S, Tani M, Kawai M, Ushijima M, Matsuura M, Saiki Y, Saiura A, Yamamoto J, Miki Y, Noda T: Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling. Cancer Sci. 101(1): 259-66, 2010
  17. Tominaga T, Iwahashi M, Takifuji K, Hotta T, Yokoyama S, Matsuda K, Higashiguchi T, Oku Y, Nasu T, Yamaue H: Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer. Int J Cancer. 126(7): 1691-701, 2010
  18. Kawai M, Tani M, Kobayashi Y, Tuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T, Yamaue H: The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg 199(4): 447-52, 2010
  19. Matsuda K, Hotta T, Takifuji K, Yokoyama S, Oku Y, Yamaue H: Clinicopathological features o f anastomotic recurrence after an anterior resection for rectal cancer. Langenbecks Arch Surg 395(3): 235-9, 2010
  20. Hirono S, Yamaue H: Middle pancreatectomy for pancreatic neoplasms. J Hepatobiliary Pancreat Sci. 17(6): 803-7, 2010